Case report
Open access
Oct 2026
Clinical Response to Upadacitinib in Treatment-Experienced Patients With Atopic Dermatitis: A Case Series From Latin America
Atopic dermatitis (AD) is a chronic inflammatory skin disease that may require systemic therapy in patients with persistent disease activity or an inadequate response to previous treatments. Upadacitinib, a selective Janus kinase 1 inhibitor, has demonstrated rapid clinical efficacy in patients with moderate-to-severe...
Ana B. Crocker Sandoval, Y. N. Lozano-Figueroa, Ana G. Perez-Romero et al.
· Cureus · 0 citations